Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared ...

It is a non-randomised, single-arm, open-label, multi-centre, diagnostic clinical trial of 64 Cu-SAR-bisPSMA positron emission tomography (PET) in participants with rising or detectable prostate ...

A diagnosis identifies a patient’s health problem ... with non-investigator physicians during the course of the trial, the patients’ participation was not documented in any of their medical ...

A new diagnostic which could transform the detection of cancer is about to enter a pivotal, large-scale trial. Owlstone Medical’s Breath Biopsy is a novel device which promises to detect cancer ...

Ultrasound was not performed in 39% of D-dimer patients. In this trial, a diagnostic strategy that involved D-dimer testing and selective ultrasonography performed as well as a strategy of ...

AOA Dx Inc. closed an oversubscribed $17 million seed round to expand the clinical trial for its ovarian cancer diagnostic test, build out new lab facilities and explore applications of its ...

At the conclusion of the trial, a final diagnosis was determined for each participant by consensus of an expert panel that consisted of a pediatric radiologist, a pediatric orthopedic surgeon ...

The trial’s results suggest that emphasizing the first line of treatment and giving the most effective therapy straight after diagnosis is particularly important for patients with high-risk ...

It is a non-randomised, single-arm, open-label, multi-centre, diagnostic clinical trial of 64 Cu-SAR-bisPSMA positron emission tomography (PET) in participants with rising or detectable ...